Ropes Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $6.67M | Sell |
201,003
-18,896
| -9% | -$668K | 1.29% | 18 |
|
|
2023
Q2 | $8.07M | Buy |
219,899
+7,439
| +4% | +$290K | 1.34% | 16 |
|
|
2023
Q1 | $8.67M | Sell |
212,460
-6,041
| -3% | -$261K | 1.57% | 13 |
|
|
2022
Q4 | $11.2M | Sell |
218,501
-6,098
| -3% | -$292K | 2.01% | 7 |
|
|
2022
Q3 | $9.83M | Buy |
224,599
+41,472
| +23% | +$2.02M | 2.07% | 8 |
|
|
2022
Q2 | $9.6M | Buy |
183,127
+331
| +0.2% | +$16.9K | 1.97% | 8 |
|
|
2022
Q1 | $9.46M | Sell |
182,796
-10,042
| -5% | -$521K | 1.62% | 11 |
|
|
2021
Q4 | $11.4M | Sell |
192,838
-7,829
| -4% | -$388K | 2% | 6 |
|
|
2021
Q3 | $8.63M | Sell |
200,667
-101
| -0.1% | -$4.47K | 1.38% | 11 |
|
|
2021
Q2 | $7.86M | Buy |
200,768
+10,612
| +6% | +$413K | 1.24% | 14 |
|
|
2021
Q1 | $7.48M | Sell |
190,156
-6,141
| -3% | -$218K | 1.31% | 13 |
|
|
2020
Q4 | $7.23M | Buy |
196,297
+1,770
| +0.9% | +$64.9K | 1.12% | 14 |
|
|
2020
Q3 | $6.77M | Sell |
194,527
-7,003
| -3% | -$246K | 1.31% | 11 |
|
|
2020
Q2 | $6.25M | Sell |
201,530
-643
| -0.3% | -$21.8K | 1.28% | 12 |
|
|
2020
Q1 | $6.26M | Buy |
202,173
+983
| +0.5% | +$33.5K | 1.58% | 10 |
|
|
2019
Q4 | $7.48M | Sell |
201,190
-11,993
| -6% | -$427K | 1.61% | 8 |
|
|
2019
Q3 | $7.27M | Buy |
213,183
+1,356
| +0.6% | +$49.3K | 1.54% | 11 |
|
|
2019
Q2 | $8.71M | Sell |
211,827
-11,376
| -5% | -$452K | 1.84% | 7 |
|
|
2019
Q1 | $8.99M | Sell |
223,203
-2,223
| -1% | -$89K | 2.38% | 6 |
|
|
2018
Q4 | $9.34M | Sell |
225,426
-4,217
| -2% | -$175K | 2.69% | 7 |
|
|
2018
Q3 | $9.6M | Sell |
229,643
-3,943
| -2% | -$152K | 2.37% | 7 |
|
|
2018
Q2 | $8.04M | Sell |
233,586
-9,740
| -4% | -$333K | 2.17% | 7 |
|
|
2018
Q1 | $8.19M | Sell |
243,326
-761
| -0.3% | -$26.2K | 2.24% | 9 |
|
|
2017
Q4 | $8.39M | Sell |
244,087
-3,929
| -2% | -$134K | 2.2% | 7 |
|
|
2017
Q3 | $8.4M | Buy |
248,016
+1,070
| +0.4% | +$34.4K | 2.28% | 8 |
|
|
2017
Q2 | $7.87M | Sell |
246,946
-883
| -0.4% | -$27.8K | 2.23% | 8 |
|
|
2017
Q1 | $8.04M | Buy |
247,829
+11,519
| +5% | +$363K | 2.32% | 8 |
|
|
2016
Q4 | $7.28M | Buy |
236,310
+3,393
| +1% | +$104K | 2.28% | 8 |
|
|
2016
Q3 | $7.49M | Buy |
232,917
+10,366
| +5% | +$347K | 2.53% | 6 |
|
|
2016
Q2 | $7.43M | Buy |
222,551
+51,064
| +30% | +$1.63M | 2.59% | 6 |
|
|
2016
Q1 | $4.82M | Buy |
171,487
+3,001
| +2% | +$85.7K | 2.13% | 11 |
|
|
2015
Q4 | $5.16M | Buy |
168,486
+100
| +0.1% | +$3.15K | 2.27% | 9 |
|
|
2015
Q3 | $5.02M | Buy |
168,386
+5,593
| +3% | +$179K | 2.63% | 6 |
|
|
2015
Q2 | $5.18M | Hold |
162,793
| – | – | 2.81% | 5 |
|
|
2015
Q1 | $5.37M | Buy |
+162,793
| New | +$5.18M | 2.79% | 6 |
|
Other funds holding PFE
Ropes Wealth Advisors's PFE Position: Q3 2023 in Review
Ropes Wealth Advisors reduced its Pfizer (PFE) stake by 8.6% in Q3 2023, selling an estimated $668K and leaving 201,003 shares worth $6.67M. The position accounts for 1.29% of the portfolio, ranked #18.
Ropes Wealth Advisors first reported a position in PFE in Q1 2015 and has held it in 35 quarters since. The position peaked at $11.4M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Ropes Wealth Advisors held 201,003 shares of Pfizer worth $6.67M as of Q3 2023.
- Ropes Wealth Advisors sold 18,896 Pfizer shares in Q3 2023, an estimated $668K.
- Pfizer made up 1.29% of Ropes Wealth Advisors's portfolio in Q3 2023, its #18 holding.
- Ropes Wealth Advisors first reported a position in Pfizer in Q1 2015 and has held it in 35 quarters since.
- Ropes Wealth Advisors's Pfizer position peaked at $11.4M in Q4 2021.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.